The conserved amphipatic alpha-helical core motif of RARgamma and RARalpha activating domains is indispensable for RA-induced differentiation of F9 cells

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Plassat, J.
	Articles by Rochette-Egly, C.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Plassat, J.
	Articles by Rochette-Egly, C.

Abu-Abed, S. S., Beckett, B. R., Chiba, H., Chithalen, J. V., Jones, G., Metzger, D., Chambon, P. and Petkovich, M (1998). Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J. Biol. Chem 273, 2409-2415.[Abstract/Free Full Text]

Adra, C. N., Boer, P. H. and McBurney, M. W (1987). Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60, 65-74.[Medline]

Becker, S., Wang, Z. J., Massey, H., Arauz, A., Labosky, P., Hammerschmidt, M., St-Jacques, B., Bumcrot, D., McMahon, A. and Grabel, L (1997). A role for Indian hedgehog in extraembryonic endoderm differentiation in F9 cells and the early mouse embryo. Dev. Biol 187, 298-310.[Medline]

Benoit, G., Altucci, L., Flexor, M., Ruchaud, S., Lillehaug, J. Raffelsberger, W., Gronemeyer, H. and Lanotte, M (1999). RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. EMBO J 18, 7011-7018.[Medline]

Bouillet, P., Oulad-Abdelghani, M., Vicaire, S., Garnier, J. M., Schuhbaur, B., Dolle, P. and Chambon, P (1995). Efficient cloning of cDNAs of retinoic acid-responsive genes in P19 embryonal carcinoma cells and characterization of a novel mouse gene, Stra1 (mouse LERK-2/Eplg2). Dev. Biol 170, 420-433.[Medline]

Boylan, J. F., Lohnes, D., Taneja, R., Chambon, P. and Gudas, L. J (1993). Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc. Nat. Acad. Sci. USA 90, 9601-9605.[Abstract/Free Full Text]

Boylan, J. F., Lufkin, T., Achkar, C. C., Taneja, R., Chambon, P. and Gudas, L. J (1995). Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. Cell Biol 15, 843-851.[Abstract]

Brocard, J., Kastner, P. and Chambon, P (1996). Two novel RXR alpha isoforms from mouse testis. Biochem. Biophys. Res. Commun 229, 211-218.[Medline]

Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P. J. and Parker, M. G (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14, 3741-3751.[Medline]

Chambon, P (1994). The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol 5, 115-125.[Medline]

Chambon, P (1996). A decade of molecular biology ot retinoic acid receptors. FASEB. J 10, 940-954.[Abstract]

Chiba, H., Clifford, J., Metzger, D. and Chambon, P (1997). Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells. J. Cell Biol 139, 735-747.[Abstract/Free Full Text]

Chiba, H., Clifford, J., Metzger, D. and Chambon, P (1997). Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol. Cell Biol 17, 3013-3020.[Abstract]

Clifford, J., Chiba, H., Sobieszczuk, D., Metzger, D. and Chambon, P (1996). RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J 15, 4142-4155.[Medline]

Costa, S. L. and Mc Burney, M. W (1996). Dominant negative mutant of retinoic acid receptor alpha inhibits retinoic acid-induced P19 cell differentiation by binding to DNA. Exp. Cell Res 225, 35-43.[Medline]

Damm, K. R., Heyman, R., Umezono, K. and Evans, R. M (1993). Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Nat. Acad. Sci. USA 90, 2989-2993.[Abstract/Free Full Text]

Dittman, W. A., Kumada, T., Sadler, J. E. and Majerus, P. W (1988). The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells. J. Biol. Chem 263, 15815-15822.[Abstract/Free Full Text]

Dittman, W. A., Nelson, S. C., Greer, P. K., Horton, E. T., Palomba, M. L. and McCachren, S. S (1994). Characterization of thrombomodulin expression in response to retinoic acid and identification of a retinoic acidresponse element in the human thrombomodulin gene. J. Biol. Chem 269, 16925-16932.[Abstract/Free Full Text]

Durand, B., Saunders, M., Gaudon, C., Roy, B., Losson, R. and Chambon, P (1994). Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 13, 5370-5382.[Medline]

Folkers, G. E., van Heerde, E. C. and van der Saag, P. T (1995). Activation function 1 of retinoic acid receptor beta 2 is an acidic activator resembling VP16. J. Biol. Chem 270, 23552-23559.[Abstract/Free Full Text]

Fujii, H., Sato, T., Kaneko, S., Gotoh, O., Fujii-Kuriyama, Y., Osawa, K., Kato, S. and Hamada, H (1997). Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J 16, 4163-4173.[Medline]

Gaub, M. P., Rochette-Egly, C., Lutz, Y., Ali, S., Matthes, H., Scheuer, I. and Chambon, P (1992). Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp. Cell Res 201, 335-346.[Medline]

Ghyselinck, N. B., Dupe, V., Dierich, A., Messaddeq, N., Garnier, J. M., Rochette-Egly, C., Chambon, P. and Mark, M (1997). Role of the retinoic acid receptor beta (RARbeta) during mouse development. Int. J. Dev. Biol 41, 425-447.[Medline]

Gronemeyer, H. and Laudet, V (1995). Transcription factors 3: nuclear receptors. Protein Profile 2, 1173-1308.[Medline]

Gudas, L. J (1994). Retinoids and vertebrate development. J. Biol. Chem 269, 15399-15402.[Abstract/Free Full Text]

Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R (1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59.[Medline]

Kastner, P., Mark, M. and Chambon, P (1995). Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?. Cell 83, 859-869.[Medline]

Kastner, P., Mark, M., Ghyselinck, N., Krezel, W., Dupe, V., Grondona, J. M. and Chambon, P (1997). Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development 124, 313-326.[Abstract]

Krowczynska, A. M., Coutts, M., Makrides, S. and Brawerman, G (1989). The mouse homologue of the human acidic ribosomal phosphoprotein PO: a highly conserved polypeptide that is under translational control. Nucl. Acids Res 17, 6408-.[Free Full Text]

Kruyt, F. A., van der Veer, L. J., Mader, S., van den Brink, C. E., Feijen, A., Jonk, L. J., Kruijer, W. and van der Saag, P. T (1992). Retinoic acid resistance of the variant embryonal carcinoma cell line RAC65 is caused by expression of a truncated RAR alpha. Differentiation 49, 27-37.[Medline]

Le Douarin, B., Zechel, C., Garnier, J. M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P. and Losson, R (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14, 2020-2033.[Medline]

Leid, M., Kastner, P. and Chambon, P (1992). Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci 17, 427-433.[Medline]

Mangelsdorf, D. J. and Evans, R. M (1995). The RXR heterodimers and orphan receptors. Cell 83, 841-850.[Medline]

Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. et al (1995). The nuclear receptor superfamily: the second decade. Cell 83, 835-839.[Medline]

Mascrez, B., Mark, M., Dierich, A., Ghyselinck, N. B., Kastner, P. and Chambon, P (1998). The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 125, 4691-4707.[Abstract]

Meyer, M. E., Gronemeyer, H., Turcotte, B., Bocquel, M. T., Tasset, D. and Chambon, P (1989). Steroid Hormone receptors compete for factors that mediate their enhancer function. Cell 57, 433-442.[Medline]

Moras, D. and Gronemeyer, H (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol 10, 384-391.[Medline]

Nagpal, S., Saunders, M., Kastner, P., Durand, B., Nakshatri, H. and Chambon, P (1992). Promoter context-and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell 70, 1007-1019.[Medline]

Nagpal, S., Friant, S., Nakshatri, H. and Chambon, P (1993). RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J 12, 2349-2360.[Medline]

Niforas, P., Chu, M. D. and Bird, P (1996). A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. Gene 176, 139-147.[Medline]

Pahl, H. L. and Baeuerle, P. A (1999). Control of gene expression by proteolysis. Curr. Opin. Cell Biol 8, 340-347.

Pratt, M. A., Kralova, J. and McBurney, M. W (1990). A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol. Cell Biol 10, 6445-6453.[Abstract/Free Full Text]

Renaud, J. P., Rochel, N., Ruff, M., Vivat, V., Chambon, P., Gronemeyer, H. and Moras, D (1995). Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.[Medline]

Rochette-Egly, C., Lutz, Y., Saunders, M., Scheuer, I., Gaub, M. P. and Chambon, P (1991). Retinoic acid receptor gamma: specific immunodetection and phosphorylation. J. Cell Biol 115, 535-545.[Abstract/Free Full Text]

Schulman, I. G., Juguilon, H. and Evans, R. M (1996). Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell Biol 16, 3807-3813.[Abstract]

Strickland, S. and Mahdavi, V (1978). The induction of differentiation in teratocarcinoma cells by retinoic acid. Cell 15, 393-403.[Medline]

Strickland, S., Smith, K. K. and Marotti, K. R (1980). Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21, 347-355.[Medline]

Taneja, R., Bouillet, P., Boylan, J. F., Gaub, M. P., Roy, B., Gudas, L. J. and Chambon, P (1995). Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc. Nat. Acad. Sci. USA 92, 7854-7858.[Abstract/Free Full Text]

Taneja, R., Roy, B., Plassat, J. L., Zusi, C. F., Ostrowski, J., Reczek, P. R. and Chambon, P (1996). Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Nat. Acad. Sci. USA 93, 6197-6202.[Abstract/Free Full Text]

Taneja, R., Rochette-Egly, C., Plassat, J. L., Penna, L., Gaub, M. P. and Chambon, P (1997). Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J 16, 6452-6465.[Medline]

Tasset, D., Tora, L., Fromental, C., Scheer, E. and Chambon, P (1990). Distinct classes of transcriptional activating domains function by different mechanisms. Cell 62, 1177-1187.[Medline]

Valentini, R. P., Brookhiser, WT., Park, J., Yang, T., Briggs, J., Dressler,G. and Holzman, L. B (1997). Post-translational processing and renal expression of mouse Indian Hedgehog. J. Biol. Chem 272, 8466-8473.[Abstract/Free Full Text]

Voegel, J. J., Heine, M. J., Zechel, C., Chambon, P. and Gronemeyer, H (1996). TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15, 3667-3675.[Medline]

vom Baur, E., Zechel, C., Heery, D., Heine, M. J., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P. and Losson, R (1996). Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15, 110-124.[Medline]

Wan, Y. J., Wang, L. and Wu, T. C (1994). The expression of retinoid X receptor genes is regulated by all-trans-and 9-cis-retinoic acid in F9 teratocarcinoma cells. Exp. Cell Res 210, 56-61.[Medline]

Wurtz, J. M., Bourguet, W., Renaud, J. P., Vivat, V., Chambon, P., Moras, D. and Gronemeyer, H (1996). A canonical structure for the ligand-binding domain of nuclear receptors. Nature Struct. Biol 3, 206-.[Medline]

Xu, L., Glass, C. K. and Rosenfeld, M. G (1999). Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev 9, 140-147.[Medline]

Zelent, A., Krust, A., Petkovich, M., Kastner, P. and Chambon, P (1989). Cloning of murine alpha and beta retinoic acid receptors and a novel receptor gamma predominantly expressed in skin. Nature 339, 714-717.[Medline]

This article has been cited by other articles:

E. Parrella, M. Gianni, M. Fratelli, M. M. Barzago, I. Raska Jr, L. Diomede, M. Kurosaki, C. Pisano, P. Carminati, L. Merlini, et al.
Antitumor Activity of the Retinoid-Related Molecules (E)-3-(4'-Hydroxy-3'-adamantylbiphenyl-4-yl)acrylic Acid (ST1926) and 6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalene Carboxylic Acid (CD437) in F9 Teratocarcinoma: Role of Retinoic Acid Receptor {gamma} and Retinoid-Independent Pathways
Mol. Pharmacol., September 1, 2006; 70(3): 909 - 924.
[Abstract] [Full Text] [PDF]

M. Gianni, A. Tarrade, E. A. Nigro, E. Garattini, and C. Rochette-Egly
The AF-1 and AF-2 Domains of RAR{gamma}2 and RXR{alpha} Cooperate for Triggering the Transactivation and the Degradation of RAR{gamma}2/RXR{alpha} Heterodimers
J. Biol. Chem., September 5, 2003; 278(36): 34458 - 34466.
[Abstract] [Full Text] [PDF]

J. Bastien, S. Adam-Stitah, J.-L. Plassat, P. Chambon, and C. Rochette-Egly
The Phosphorylation Site Located in the A Region of Retinoic X Receptor alpha Is Required for the Antiproliferative Effect of Retinoic Acid (RA) and the Activation of RA Target Genes in F9 Cells
J. Biol. Chem., August 2, 2002; 277(32): 28683 - 28689.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Plassat, J.

Articles by Rochette-Egly, C.

Search for Related Content

PubMed

PubMed Citation

Articles by Plassat, J.

Articles by Rochette-Egly, C.

				M. Gianni, A. Tarrade, E. A. Nigro, E. Garattini, and C. Rochette-Egly The AF-1 and AF-2 Domains of RAR{gamma}2 and RXR{alpha} Cooperate for Triggering the Transactivation and the Degradation of RAR{gamma}2/RXR{alpha} Heterodimers J. Biol. Chem., September 5, 2003; 278(36): 34458 - 34466. [Abstract] [Full Text] [PDF]

				J. Bastien, S. Adam-Stitah, J.-L. Plassat, P. Chambon, and C. Rochette-Egly The Phosphorylation Site Located in the A Region of Retinoic X Receptor alpha Is Required for the Antiproliferative Effect of Retinoic Acid (RA) and the Activation of RA Target Genes in F9 Cells J. Biol. Chem., August 2, 2002; 277(32): 28683 - 28689. [Abstract] [Full Text] [PDF]